Mark J Gergen insider trades

Open-market stock purchases and sales by Mark J Gergen, President and CEO at Poseida Therapeutics, Inc, from SEC Form 4 filings since Feb 2, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • PSTX Poseida Therapeutics, Inc: 2 sales, last Jan 8, 2025
  • HALO Halozyme Therapeutics Inc: other filings, last Feb 22, 2017
  • MRTX Mirati Therapeutics, Inc: 1 sale, last Jan 22, 2016
  • AMLN Amylin Pharmaceuticals Inc: 2 sales, last Aug 8, 2012

Get free alerts when Mark J Gergen files a new trade →